Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of emerging genomics and proteomics technologies in cancer drug target discovery.

Current cancer drug targets - 1 Mar 2004

Onyango Patrick

Abstract excerpt

Cancer drugs have traditionally been identified in screens designed to produce broad biological end points such as cell death. A serious undesired outcome of drugs discovered in these screens is that the mechanism of drug action is unknown and such drugs often have adverse side effects. Designing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Computational Biology
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Endpoint Determination

Share to Genomics

Share to Proteomics

Share to RNA, Neoplasm

Source

Identifiers

PMID: 15032664
DOI: 10.2174/1568009043481588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15032664-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of emerging genomics and proteomics technologies in cancer drug target discovery.PMID 15032664Read ↗

Role of genomics in identifying new targets for cancer therapy.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Implications of genome-wide association studies in cancer therapeutics.Semantic proximity Read ↗

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized MedicineSemantic proximity Read ↗

Impact of Genomics on Personalized Cancer MedicineSemantic proximity Read ↗

A comprehensive map of molecular drug targets.Semantic proximity Read ↗

Pharmacogenomic discovery approaches: will the real genes please stand up?Semantic proximity Read ↗

Using bioinformatics for drug target identification from the genome.Semantic proximity Read ↗

Exploiting the Cancer Genome: Strategies for the Discovery and Clinical Development of Targeted Molecular TherapeuticsSemantic proximity Read ↗

Pharmacogenomic biomarkers for personalized cancer treatment.Semantic proximity Read ↗

Choosing anticancer drug targets in the postgenomic era.Semantic proximity Read ↗

Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.